ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $494,437 | +22.5% | 18,218 | +38.8% | 0.01% | +40.0% |
| Q2 2023 | $403,555 | -14.8% | 13,128 | -0.1% | 0.01% | -28.6% |
| Q1 2023 | $473,542 | -8.4% | 13,143 | +0.5% | 0.01% | -12.5% |
| Q4 2022 | $516,922 | +80.7% | 13,080 | +84.0% | 0.01% | +60.0% |
| Q3 2022 | $286,000 | -2.1% | 7,108 | +2.2% | 0.01% | -16.7% |
| Q2 2022 | $292,000 | -68.0% | 6,955 | -70.3% | 0.01% | -60.0% |
| Q1 2022 | $912,000 | -1.3% | 23,397 | +1.0% | 0.02% | +7.1% |
| Q4 2021 | $924,000 | +12.1% | 23,175 | +1.7% | 0.01% | -12.5% |
| Q3 2021 | $824,000 | -16.9% | 22,794 | -5.7% | 0.02% | -11.1% |
| Q2 2021 | $991,000 | +58.1% | 24,172 | +68.1% | 0.02% | +38.5% |
| Q1 2021 | $627,000 | +164.6% | 14,379 | +203.4% | 0.01% | +160.0% |
| Q4 2020 | $237,000 | – | 4,739 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |